Skip Navigation



NDT Advance Access published online on January 25, 2005

Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfh671
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
20/3/618    most recent
gfh671v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Karamperis, N.
Right arrow Articles by Jørgensen, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karamperis, N.
Right arrow Articles by Jørgensen, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant © ERA-EDTA 2004; all rights reserved
Received March 13, 2004
Accepted August 31, 2004


Original Articles

Role of metabolites and calcineurin inhibition on C2 monitoring in renal transplant patients

Nikolaos Karamperis 1, Pernille Koefoed-Nielsen 1, Anette Bagger Sørensen 1, Carsten Højskov 2, Jørgen Poulsen 2, and Kaj Jørgensen 1*

1 Research Laboratory, Department of Renal Medicine C, Århus University Hospital, Århus, Denmark
2 Department of Clinical Chemistry, Århus Kommunehospital, Århus University Hospital, Århus, Denmark

* To whom correspondence should be addressed.
Kaj Jørgensen, E-mail: kaj{at}dadlnet.dk



  Abstract

Background. Many transplantation centres have switched to C2 monitoring of cyclosporin-treated renal transplant patients. The rationale is that the C2 correlates best with AUC0-4 (area under the concentration-time curve), which again correlates with rejection and nephrotoxicity. It has also been demonstrated that calcineurin phosphatase is inhibited maximally 1-2 h after intake of cyclosporin in patients receiving their first dose. Cyclosporin is metabolized to many compounds, which may influence the results of immunoassays. Some metabolites may have immunosuppressive activity.

Methods. Cyclosporin metabolites were added to whole blood from healthy volunteers and the calcineurin phosphatase activity (CaN) was determined. Twenty renal transplant patients at varying times after transplantation had blood samples drawn in the morning before and 1, 2, 3 and 4 h after intake of their usual dose of cyclosporin microemulsion. Whole blood samples were analysed by liquid chromatography/tandem mass spectrometry for cyclosporin blood concentration and for the cyclosporin metabolites AM1, AM9, AM1c and AM4n. All samples were analysed for CaN utilizing a 32P-labelled 19 amino-acid peptide.

Results. The concentrations of AM1c and AM4n were very low and cannot contribute to CaN inhibition. The ratio of AM1 and AM9 to cyclosporin was high before intake of the drug, but it was much lower during the following 4 h. The 2-h values of cyclosporin were the best predictors of AUC0-4. Calcineurin phosphatase was most inhibited in the 2-h samples and the 2-h value of CaN was the best predictor of CaN AUC0-4. The correlation with calcineurin inhibition seemed better for cyclosporin plus metabolites than for cyclosporin.

Conclusions. Samples collected at 2 h are the best predictors of AUC0-4 for both cyclosporin and calcineurin inhibition. The impact of metabolites appears to be small; however, the temporal profile of calcineurin inhibition seemed to follow cyclosporin plus metabolites better than cyclosporin alone.

Keywords: AUC0-4; C2 monitoring; calcineurin activity; cyclosporin; metabolites.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
B. Jespersen, H. C. Thiesson, C. Henriksen, K. Therland, C. Falk, T. Poulsen, B. Fogh, K. Madsen, S. Walther, and B. L. Jensen
Differential effects of immunosuppressive drugs on COX-2 activity in vitro and in kidney transplant patients in vivo
Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1644 - 1655.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Buchler, S. Chadban, E. Cole, K. Midtvedt, E. Thervet, H. Prestele, and P. Keown
Evolution of the absorption profile of cyclosporine A in renal transplant recipients: a longitudinal study of the de novo and maintenance phases
Nephrol. Dial. Transplant., January 1, 2006; 21(1): 197 - 202.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.